Requests similar to 'Shortage of Phenelzine sulphate'
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs
Attached is PHARMAC's response to your recent information request.
Kind regards
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...
Management of Dexamfetamine supply
Response by Pharmaceutical Management Agency to Anita Easton on .
Partially successful.
Dear Anita
Please find attached PHARMAC’s response to your recent OIA request.
Kind regards
Victoria London
PHARMAC
15 Feb...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison,
PHARMAC is extending the response date for your request, please see letter attached.
Please let me know if you have any questions o...
Shortage of prescribed medication Concerta
Response by Pharmaceutical Management Agency to gerald on .
Awaiting classification.
Kia ora Gerald
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
__...
Testing and Therapeutics Technical Advisory Groups documents
Response by Ministry of Health to Harold on .
Successful.
Kia ora Harold
Please find attached a response to your request for official information
[H202204655]. Please accept our apologies for the de...
Oestradiol (Estradot) patches, Oestradiol gel and other products
Response by Pharmaceutical Management Agency to M Williams on .
Partially successful.
Kia ora,
Please find a response to your Official Information Act request attached.
Thank you
Government Services - Pharmac
5 June 2024
M Williams
V...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find attached a response to your request for information about
remdesivir.
Ngā mihi
Melody Willis ([1]she/h...
Arrow Venlafaxine needs to come back under NZ funding.
Response by Pharmaceutical Management Agency to VICKI CAREY on .
Partially successful.
Kia ora Vicki
Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR
and Efexor XR brands were removed when it was doing good f...
Cost of PreP since funding began in 2018
Response by Pharmaceutical Management Agency to Elliot Ikilei on .
Successful.
Kia ora Elliot
Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.
Please feel free to...
Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine
Request sent to Pharmaceutical Management Agency by John Armstrong on .
Awaiting classification.
This information pertains to your media release, dated 1 September 2025 as per the link: https://www.pharmac.govt.nz/news-and-resources/news/pharmac...
Dispensed drugs, media and events information request
Response by Pharmaceutical Management Agency to Joe Heihei on .
Awaiting classification.
Dear Joe
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
25 May 2018
Dear Joe
REQUEST FO...
Request for Information Regarding Hospital Policies on Medication Use, Specifically Medical Cannabis
Response by Ministry of Health to Anthony-John van Duuren on .
Awaiting classification.
Kia ora Anthony-John,
Thank you for your request for information regarding medicinal cannabis on
9 May 2024. Please find attached our response to...
Comirnaty (JN.1) vaccine
Response by Pharmaceutical Management Agency to Catherine Jamieson on .
Successful.
Kia ora Catherine
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
COVID-19 Health System Preparedness Programme
Response by Ministry of Health to Harold on .
Successful.
Kia ora Harold,
The second part of the response documents is attached to this email.
Ngā mihi
OIA Services Team
M[1]inistry of Health inf...
Cancer drugs v other drugs
Response by Pharmaceutical Management Agency to Brendon Mills on .
Successful.
Kia ora Brendon
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
_...
Meeting notes and outcomes
Response by Pharmaceutical Management Agency to A L.C on .
Awaiting classification.
Kia ora AL.C,
Please find attached the final part of your response, to your Official
Information Act request.
Please contact us if you hav...
Missed time from work considered?
Response by Pharmaceutical Management Agency to PCBS on .
Successful.
Kia ora Paul
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
2 Jul...
Kia ora Al,
Thank you for your request for copies of two aides memoire and a
briefing on 26 August 2024. Please find attached our response to your...
Kia ora A Mark
Please find attached a response to your request for information regarding
funding decisions for Trikafta.
Ngā mihi
...
As I understand Close Control prescritions ended 1 July 2012, is this correct ?.
If it is correct I have noticed Zopiclone is NOT on the list of "sa...
Kia ora Ms Faulkner,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pāt...
Prescription charges from 1990 to 2023
Response by Ministry of Health to Brendon Mills on .
Successful.
Kia ora koutou Brendon,
Thank you for your request for information. Please find attached our
response to your request.
If you have any questio...
Public knowledge of communication
Response by Pharmaceutical Management Agency to A L.C on .
Successful.
Kia ora
Please find attached a response to your request for official information.
Ngā mihi
Government Services | Pharmac
______...
Ordering Moderna's Bivalent vaccine
Response by Pharmaceutical Management Agency to Athina Andonatou on .
Successful.
Hi Athina,
Please find a response to your request attached to this email.
Kind regards,
Gendi
13 October 2022
Athina Andonatou
Via email: [FOI #205...
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear R Whyte
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
16 April 2018
Via Email: [e...
